Sign in

CIK 0001280776

  • Non-accelerated filer
  • Smaller reporting company

IMMUNIC, INC.

Sign in to watch
Ticker
IMUX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562358443
Phone
+1 332-255-9818
Business address
1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
Former names
VITAL THERAPIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-29 Whaley Glenn Chief Financial Officer Grant or award · Stock Option +120,000 120,000
2025-07-16 Whaley Glenn Chief Financial Officer Grant or award · Stock Appreciation Right +280,000 280,000
2025-07-16 Whaley Glenn Chief Financial Officer Grant or award · Stock Appreciation Right +560,000 560,000
2025-07-16 Whaley Glenn Chief Financial Officer Grant or award · Stock Appreciation Right +560,000 560,000
2025-07-16 Whaley Glenn Chief Financial Officer Grant or award · Stock Appreciation Right +280,000 280,000
2025-07-16 Whaley Glenn Chief Financial Officer Grant or award · Stock Appreciation Right +280,000 280,000
2025-06-05 Whaley Glenn Chief Financial Officer Grant or award · Stock Option +503,500 503,500
2025-06-05 Whaley Glenn Chief Financial Officer Grant or award · Stock Option +503,000 503,000
2025-06-03 Whaley Glenn Chief Financial Officer Purchase +45,000 $0.71 $32K 95,510
2025-05-30 Whaley Glenn Chief Financial Officer Grant or award +25,000 $0.56 $14K 50,510
2024-12-04 Whaley Glenn Chief Financial Officer Grant or award · Stock Option +265,000 265,000
2024-03-04 Whaley Glenn Chief Financial Officer Returned to the company · Stock Option −15,000 0
2024-03-04 Whaley Glenn Chief Financial Officer Returned to the company · Stock Option −15,000 0
2024-03-04 Whaley Glenn Chief Financial Officer Returned to the company · Stock Option −30,000 0
2024-03-04 Whaley Glenn Chief Financial Officer Returned to the company · Stock Option −40,000 0
2024-03-04 Whaley Glenn Chief Financial Officer Returned to the company · Stock Option −70,000 0
2024-03-04 Whaley Glenn Chief Financial Officer Returned to the company · Stock Option −40,000 0
2024-03-04 Whaley Glenn Chief Financial Officer Returned to the company · Stock Option −10,000 0
2024-03-04 Whaley Glenn Chief Financial Officer Grant or award · Stock Option +220,000 220,000
2024-01-17 Whaley Glenn Chief Financial Officer Grant or award · Stock Option +295,400 295,400

Page 1 of 2 · 35 trades